Markers of cardiac dysfunction in cognitive impairment and dementia

Medicine (United States)

Volumn 94, Issue 1, 2015, Pages e297-

  Hilal, Saima ^a,b   Chai, Yuek Ling ^a,b   Ikram, Mohammad Kamran ^a,b,c   Elangovan, Sakktivel ^a   Yeow, Tan Boon ^f   Xin, Xu ^a,b   Chong, Jun Yi ^a,b   Venketasubramanian, Narayanaswamy ^a,d,e   Richards, Arthur Mark ^a   Chong, Jenny P C ^a   Lai, Mitchell Kim Peng ^a,b   Chen, Christopher ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d St Luke's Hospital   (Singapore)

^e RAFFLES HOSPITAL   (Singapore)

^f Neuroscience Clinic Raffles Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGE RELATED WHITE MATTER CHANGES SCALE; AGED; ARTICLE; ASSESSMENT OF HUMANS; BRAIN INFARCTION; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WHITE MATTER LESION; BLOOD; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TROPONIN T;

EID: 84921341626     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000297     Document Type: Article

References (41)

1. Kling MA, Trojanowski JQ, Wolk DA, et al. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement. 2013;9:76-92.
2. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128:2034-2041.
3. Pantoni L, Poggesi A, Inzitari D. Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts. Cerebrovasc Dis. 2009;27:191-196.
4. Pressler SJ. Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs. 2008;23:239-249.
5. Muqtadar H, Testai FD, Gorelick PB. The dementia of cardiac disease. Curr Cardiol Rep. 2012;14:732-740.
6. Dziedzic T. Systemic inflammatory markers and risk of dementia. Am J Alzheimer"s Dis Dement. 2006;21:258-262.
7. van den Hurk K, Reijmer YD, van den Berg E, et al. Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail. 2011;13:1362-1369.
8. Gunstad J, Poppas A, Smeal S, et al. Relation of brain natriuretic peptide levels to cognitive dysfunction in adults 55 years of age with cardiovascular disease. Am J Cardiol. 2006;98:538-540.
9. Kerola T, Nieminen T, Hartikainen S, et al. B-type natriuretic peptide as a predictor of declining cognitive function and dementia-A cohort study of an elderly general population with a 5-year follow-up. Ann Med. 2010;42:207-215.
10. Dadu RT, Fornage M, Virani SS, et al. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013;44:1803-1808.
11. Webb IG, Yam ST, Cooke R, et al. Elevated baseline cardiac troponin levels in the elderly-Another variable to consider?. Heart Lung Circ. 2014(in press)
12. Kondziella D, Gothlin M, Fu M, et al. B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia. Neuroreport. 2009;20:825-827.
13. Hilal S, Ikram MK, Saini M, et al. Prevalence of cognitive impairment in Chinese: epidemiology of dementia in Singapore study. J Neurol Neurosurg Psychiatry. 2013;84:686-692.
14. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
15. Kapeller P, Barber R, Vermeulen RJ, et al. Visual rating of agerelated white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke. 2003;34:441-445.
16. Yeo D, Gabriel C, Chen C, et al. Pilot validation of a customized neuropsychological battery in elderly Singaporeans. Neurol J South East Asia. 1997:123.
17. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621-1626.
18. Porteus SD. The Maze Test and Clinical Psychology. Palo Alto, CA: Pacific Books; 1959.
19. Wechsler D. Wechsler Memory Scale-Revised. 3rd ed. San Antonio TX: Jovanovich; 1997.
20. Lewis RF, Rennick PM. Manual for the Repeatable Cognitive Perceptual-Motor Battery. Clinton Township, MI: Axon; 1979.
21. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer"s disease. J Gerontol. 1992;47:154-158.
22. Isaacs B, Kennie AT. The Set test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973;123:467-470.
23. Smith A. Symbol Digit Modalities Test. Los Angeles CA: ; 1973.
24. Diller L, Ben-Yishay Y, Gerstman LJ. Studies in Cognition and Rehabilitation in Hemiplegia. New York: New York University Medical Center Institute of Rehabilitation Medicine; 1974.
25. Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer"s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725-729.
26. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: Harcourt Brace Jovanovich; 1981.
27. Sahadevan S, Tan NJ, Tan T, Tan S. Cognitive testing of elderly Chinese people in Singapore: influence of education and age on normative scores. Age Ageing. 1997;26:481-486.
28. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
29. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer"s disease: recommendations from the National Institute on Aging-Alzheimer"s Association workgroups on diagnostic guidelines for Alzheimer"s disease. Alzheimer"s Dement. 2011;7:263-269.
30. Cohen RA, Moser DJ, Clark MM, et al. Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation. Am J Cardiol. 1999;83:1374-1378.
31. Vogels RL, Oosterman JM, van Harten B, et al. Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc. 2007;55:1764-1770.
32. Hoth KF, Poppas A, Moser DJ, et al. Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol. 2008;21:65-72.
33. Bell-McGinty S, Lopez OL, Meltzer CC, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol. 2005;62:1393-1397.
34. Saykin AJ, Wishart HA, Rabin LA, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67:834-842.
35. Naito J, Naka Y, Watanabe H. Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease. Geriatr Gerontol Int. 2009;9:242-245.
36. Daniels LB, Laughlin GA, Kritz-Silverstein D, et al. Elevated natriuretic peptide levels and cognitive function in communitydwelling older adults. Am J Med. 2011;124:670e671-e678.
37. Buerger K, Uspenskaya O, Hartmann O, et al. Prediction of Alzheimer"s disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment. J Clin Psychiatry. 2011;72:556-563.
38. Angermann CE, Frey A, Ertl G. Cognition matters in cardiovascular disease and heart failure. Eur Heart J. 2012;33:1721-1723.
39. Richards M, Di Somma S, Mueller C, et al. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure) JACC. Heart Fail. 2013;1:192-199.
40. Rost NS, Biffi A, Cloonan L, et al. Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke. 2012;43:441-445.
41. Chong AY, Blann AD, Patel J, et al. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation. 2004;110:1794-1798.